Phoenix Overseas Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Phoenix Overseas Ltd is ₹ 15.45 as of 28 Oct 15:30 . The P/E Ratio of Phoenix Overseas Ltd changed from 8.1 on March 2025 to 8.7 on March 2026 . This represents a CAGR of 3.64% over 2 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Phoenix Overseas Ltd changed from ₹ 36.95 crore on March 2025 to ₹ 30.08 crore on March 2026 . This represents a CAGR of -9.77% over 2 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Phoenix Overseas Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.46 crore. This represent the decline of -100% The ebitda of Phoenix Overseas Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ -49.86 crore as compare to the Dec '25 ebitda of ₹ 1.43 crore. This represent the decline of -3586% The net profit of Phoenix Overseas Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ -49.86 crore over 8 quarters. This represents a CAGR of 1110.98% The Dividend Payout of Phoenix Overseas Ltd changed from 7.83 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Phoenix Overseas Ltd

Phoenix Overseas Limited was originally incorporated as a Private Limited Company in the name and style of 'Phoenix Commodity Export Private Limited' dated December 31, 2002, issued by the Registrar of Companies, Kolkata.
Subsequently, Company name changed to Phoenix Overseas Private Limited and a fresh Certificate of Incorporation was issued by Registrar of Companies, Kolkata dated December 16, 2008.
Thereafter, the status of Company subsequently converted into Public Limited and name of the Company was changed to 'Phoenix Overseas Limited' and a fresh Certificate of Incorporation dated November 14, 2011, was issued by Registrar of Companies, Kolkata. Promoted by Aparesh Nandi, Jayanta Kumar Ghosh and Uday Narayan Singh, the Company is engaged into trading and exporting of agricultural produce and commodities such as corn, oil cakes, spices like dry red chilies, coriander, food grains like rice, wheat, corn, pulses and agricultural feed like soya bean meal and rice bran de-oiled cake.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Phoenix Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Phoenix Overseas Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Phoenix Overseas Ltd is 29 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Phoenix Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Phoenix Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Phoenix Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 31, 2026, the Phoenix Overseas Ltd stock price is INR ₹15.45. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Phoenix Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Phoenix Overseas Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.